Summary by Moomoo AI
Moderna, Inc. officer Shannon Thyme is set to sell 117 shares of the company's common stock on 03/04/2024, with an aggregate market value of $11,037.58. The shares were acquired on 03/01/2024 as part of a restricted stock vesting agreement with the issuer, Moderna, and were compensation for Thyme's role within the company. This transaction follows a series of sales over the past three months, where Thyme sold a total of 1,344 shares, amounting to gross proceeds of $116,692.11.